The Senior Director, Global Forecasting will lead forecasting strategies and model development for oncology products while collaborating with various teams to support organizational decisions and enhance strategic planning.

The Senior Director will lead KOL customer strategies in lung oncology, manage a team, and drive advocacy and marketing initiatives for product launches.

The Senior Safety Scientist oversees safety management in clinical studies, develops safety documentation, and performs risk management and signal detection activities.

The Safety Scientist provides safety science and pharmacovigilance support across clinical trials, develops safety profiles, and conducts data reviews.

The Vice President of Marketing will develop revolutionary strategies for NSCLC therapies, lead marketing initiatives, manage a marketing team, establish partnerships, and effectively engage with internal and external stakeholders to promote product success.

Lead corporate communications strategies to enhance brand visibility, manage media relations, oversee digital content, and drive engagement across key audiences.

The Director, National Accounts establishes relationships with payers to ensure access to oncology medicines, drives formulary placement, and coordinates cross-functional teams.

The Vice President will lead the European Value, Market Access & Pricing team, formulating market access strategies and ensuring optimal reimbursement for products in development, especially for cancer treatments.

As a lead statistician, provide statistical leadership and support for clinical studies, collaborate on study design, and ensure compliance with regulatory requirements.

Lead global strategy and execution of medical congress activities, advisory board operations, and cross-functional collaboration in oncology medical affairs.

This role involves oversight and programming support for oncology clinical trials, ensuring quality delivery of statistical analysis, and mentorship.

The Senior Manager, GMP Quality oversees QA in drug development, collaborating with teams on compliance, process validation, and managing quality oversight for products.

The Senior Manager of GMP Quality oversees quality assurance in pharmaceutical development, ensures compliance, and leads process validation efforts across programs.

Lead cross-functional planning and execution of integrated evidence generation for oncology products, ensuring alignment across medical and commercial functions.

Lead the design and delivery of training programs to ensure effective use of critical information systems across the organization, particularly in the pharmaceutical sector.

The Vice President General Manager will lead Revolution Medicines' expansion in France, overseeing P&L, developing strategies, managing teams, and ensuring compliance with local regulations.

The VP, General Manager will lead expansion efforts in Germany, manage P&L, develop commercialization strategies, and engage stakeholders to enhance patient access to oncology treatments.

The Vice President, General Manager Italy will lead expansion efforts in Italy, managing P&L, developing strategies, and fostering relationships with stakeholders to ensure successful commercialization and market access for oncology therapies.

Lead the commercial and operational strategy for Revolution Medicines' expansion in Spain and Portugal, managing P&L, stakeholder engagement, and product launches to optimize patient access to oncology therapies.

Manage DMPK studies, acting as a liaison with CROs, ensuring quality and compliance in study protocols and monitor progress.